🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/08/1999 | 26,79 | 26,79 | 25,27 | 25,97 | -0,89% | 5,68% | 212.932 |
| 25/08/1999 | 27,14 | 27,37 | 26,20 | 26,20 | -3,45% | 4,31% | 132.782 |
| 24/08/1999 | 28,07 | 28,54 | 26,67 | 27,14 | -1,70% | 6,67% | 115.282 |
| 23/08/1999 | 27,72 | 28,07 | 27,14 | 27,60 | +0,85% | 3,38% | 79.161 |
| 20/08/1999 | 27,60 | 27,60 | 26,20 | 27,37 | +0,86% | 5,08% | 338.500 |
| 19/08/1999 | 27,14 | 29,71 | 26,43 | 27,14 | +2,65% | 12,07% | 182.876 |
| 18/08/1999 | 27,14 | 27,60 | 25,97 | 26,43 | -1,74% | 6,03% | 434.440 |
| 17/08/1999 | 31,82 | 32,75 | 25,97 | 26,90 | -27,67% | 21,32% | 1.113.658 |
| 16/08/1999 | 36,96 | 37,66 | 36,49 | 37,20 | +0,00% | 3,16% | 28.133 |
| 13/08/1999 | 36,49 | 37,90 | 35,56 | 37,20 | +0,00% | 6,41% | 27.037 |
| 12/08/1999 | 36,03 | 37,43 | 35,56 | 37,20 | +3,25% | 5,19% | 36.121 |
| 11/08/1999 | 34,15 | 36,49 | 34,15 | 36,03 | +4,76% | 6,85% | 50.895 |
| 10/08/1999 | 35,32 | 35,32 | 33,69 | 34,39 | -2,00% | 4,64% | 30.671 |
| 09/08/1999 | 34,39 | 35,32 | 34,15 | 35,09 | +1,35% | 3,40% | 14.427 |
| 06/08/1999 | 34,62 | 35,79 | 33,69 | 34,62 | -3,90% | 6,08% | 24.072 |
| 05/08/1999 | 34,74 | 36,03 | 33,69 | 36,03 | +1,99% | 6,73% | 22.362 |
| 04/08/1999 | 35,09 | 36,49 | 34,62 | 35,32 | +2,72% | 5,33% | 23.431 |
| 03/08/1999 | 36,03 | 37,20 | 34,27 | 34,39 | -3,92% | 8,12% | 53.994 |
| 02/08/1999 | 37,90 | 37,90 | 35,56 | 35,79 | -5,56% | 6,17% | 36.228 |
| 30/07/1999 | 35,56 | 37,90 | 35,09 | 37,90 | +9,46% | 7,89% | 52.792 |
| 29/07/1999 | 37,20 | 37,43 | 34,15 | 34,62 | -6,33% | 8,81% | 69.971 |
| 28/07/1999 | 37,66 | 38,83 | 36,03 | 36,96 | -4,82% | 7,45% | 45.739 |
| 27/07/1999 | 37,31 | 38,83 | 36,03 | 38,83 | +6,41% | 7,52% | 41.170 |
| 26/07/1999 | 37,90 | 38,13 | 36,26 | 36,49 | -4,29% | 4,94% | 44.002 |
| 23/07/1999 | 37,90 | 38,83 | 36,96 | 38,13 | +1,24% | 4,94% | 46.460 |
| 22/07/1999 | 39,54 | 39,77 | 37,66 | 37,66 | -5,29% | 5,33% | 40.663 |
| 21/07/1999 | 37,43 | 40,00 | 37,43 | 39,77 | +6,25% | 6,88% | 44.911 |
| 20/07/1999 | 39,77 | 40,24 | 37,43 | 37,43 | -5,88% | 7,06% | 46.968 |
| 19/07/1999 | 40,24 | 40,47 | 39,30 | 39,77 | -1,73% | 2,91% | 34.945 |
| 16/07/1999 | 40,94 | 41,17 | 39,77 | 40,47 | -1,70% | 3,43% | 65.857 |